Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  allogeneic tumor cell vaccine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-16 of 16 for your search:
Start Over
Vaccine Treatment for Hormone Refractory Prostate Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 19 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NLG0103, 398-04FB, NCT00105053
Vaccine Treatment for Advanced Malignant Melanoma
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NLG0104, OBA#0404-640, NCT00300612
A Phase I/II Study Of Immunization With Lymphotactin And Interleukin 2 Gene Modified Neuroblastoma Tumor Cells
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Under 21
Sponsor: Other
Protocol IDs: 22053-CHESAT, NCT00703222
Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 80
Sponsor: NCI, Other
Protocol IDs: CDR0000410830, R21CA091624, UKMC-IRB-0391-F2R, UKMC-CTRF-G-01-009, NCT00103116
Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MCC-14744, P30CA076292, NIH-OBA-0608-801, MCC-104490, MCC-0534-NE, NCT00601796
Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CTN-0505, UKIRB 06-0716-F3R, ULIRB 065.07, CIRB 1079747, NCT00654030
Vaccination for the Treatment of Previously Untreated or Relapsed Follicular Lymphoma
Phase: Phase I
Type: Treatment
Status: Closed
Age: 40 and over
Sponsor: Other
Protocol IDs: 06-275, NCT00487305
Immunotherapy with BCG with or without Irradiated Allogeneic Cells for Stage I Lung Carcinoma
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-LUN-1
Allogeneic Tumor Cells During Intensive Maintenance Chemotherapy After Induction with ARA-C/ADR for Acute Myelocytic Leukemia
Phase: No phase specified
Type: Treatment
Status: Closed
Age: Under 70
Sponsor:
Protocol IDs: RPMI-DMA-970701, NCI-D78-026-209
Surgical Resection, Chemotherapy with CTX/ADR, Radiotherapy and Immunotherapy with BCG and Tumor Cells for Neuroblastoma
Phase: No phase specified
Type: Treatment
Status: Closed
Age: under 18
Sponsor:
Protocol IDs: SJCRH-NB-1, SJCRH-NB-74
Chemotherapy plus BCG Immunotherapy with or without Allogeneic Tumor Cells for Acute Myeloid Leukemia
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SWE-LGMS-AML-1
Chemotherapy with Adriamycin/Cyclophosphamide with or without BCG/Tumor Cell Vaccine Immunotherapy for Lung Carcinoma
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UARIZ-IIIB
Chemotherapy with ADR, MTX with & without Adjuvant Immunotherapy with BCG & Allogeneic Tumor Cell Vaccine in Skeletal & Soft Tissue Sarcoma
Phase: No phase specified
Type: Treatment
Status: Closed
Age: 5 to 70
Sponsor:
Protocol IDs: UCLA-SAR-1
Start Over